HS is a potent gasotransmitter in eukaryotes and bacteria. Host-derived HS has been shown to profoundly alter () energy metabolism and growth. However, compelling evidence for endogenous production of HS and its role in physiology is lacking. We show that multidrug-resistant and drug-susceptible clinical strains produce HS, whereas HS production in non-pathogenic is barely detectable. We identified Rv3684 (Cds1) as an HS-producing enzyme in and show that disruption reduces, but does not eliminate, HS production, suggesting the involvement of multiple genes in HS production. We identified endogenous HS to be an effector molecule that maintains bioenergetic homeostasis by stimulating respiration primarily via cytochrome . Importantly, HS plays a key role in central metabolism by modulating the balance between oxidative phosphorylation and glycolysis, and it functions as a sink to recycle sulfur atoms back to cysteine to maintain sulfur homeostasis. Lastly, -generated HS regulates redox homeostasis and susceptibility to anti-TB drugs clofazimine and rifampicin. These findings reveal previously unknown facets of physiology and have implications for routine laboratory culturing, understanding drug susceptibility, and improved diagnostics.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389258PMC
http://dx.doi.org/10.3390/antiox10081285DOI Listing

Publication Analysis

Top Keywords

functions sink
8
central metabolism
8
drug susceptibility
8
sink modulate
4
modulate central
4
metabolism bioenergetics
4
bioenergetics drug
4
susceptibility potent
4
potent gasotransmitter
4
gasotransmitter eukaryotes
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!